This compound is a benzimidazole derivative containing a chlorinated pyridine moiety. It is commonly used as a pharmaceutical impurity reference standard for quality control and analytical testing in the pharmaceutical industry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 103312-62-5
Methyl (1S,3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxylate
pharmaceutical raw material
8-Chloro-6-(2-fluorophenyl)-2-beta-L-glucopyranosyluronosyl-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-2-ium
pharmaceutical raw material
(R)-(-)-Citronellyl bromide
pharmaceutical raw material
1-Benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine--hydrogen chloride (1/1)
pharmaceutical raw material
Lansoprazole sulfide
pharmaceutical intermediate
Rabeprazole thioether
pharmaceutical raw material
4-Desmethoxy-4-nitro omeprazole sulfide
pharmaceutical intermediate
Ufiprazole
pharmaceutical raw material
2-[(4-chloro-3-methyl-2-pyridinyl)methylsulfanyl]-1H-benzimidazole
NKBICFMRRCFCFT-UHFFFAOYSA-N
CC1=C(C=CN=C1CSC2=NC3=CC=CC=C3N2)Cl